First, clinical characterization of selective nNOS inhibitors and NMDAR/nNOS uncouplers could unlock their potential as powerful treatments for conditions in which excitotoxicity plays an important pathophysiological role, such as status epilepticus, traumatic brain injury, and cerebral ischemia [63]. The gene discussed is NOS1; the disease is Cerebral ischemia.